Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Submit for the Fierce AI Innovation Awards, Entries close at midnight
Biotech
How Daiichi Sankyo plans to stay ahead in the ADC game
For Daiichi and its new head of R&D, the challenge is about outrunning the very ADC gold rush the company helped ignite.
Angus Liu
Jun 17, 2026 6:00pm
cAMPfield harvests $180M series A to advance oral IBD asset
Jun 18, 2026 10:34am
How NEC's AI and oral delivery system are redefining personalized cancer therapy
Brought to you by
NEC Bio
Nortiva purrs into action with long-acting Lynx platform
Jun 18, 2026 8:00am
Kardigan buttons up $400M upsized IPO for phase 3 push
Jun 18, 2026 7:28am
Biogen inks $1B RayThera buyout to bag immunology assets
Jun 18, 2026 4:10am
More News
F2G, Shionogi prep regulatory push after antifungal passes ph. 3
Jun 18, 2026 12:01am
Vedana surfaces with $46M to develop migraine prevention therapies
Jun 17, 2026 9:48am
Fierce Biotech Fundraising Tracker '26: Triveni Bio & more
Jun 17, 2026 9:30am
UniQure stock surges after FDA U-turn clears path to filing
Jun 17, 2026 9:10am
See more stories